(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

Sequel Medtech said at the American Diabetes Association's 85th Scientific Sessions that it plans to launch its twiist system ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

Ypsomed and CamDiab announced that they agreed to integrate their mylife Loop automated insulin delivery system with a future ...

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...